Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
5,421,031
-
Shares change
-
+1,757,536
-
Total reported value, excl. options
-
$48,610,180
-
Value change
-
+$15,505,635
-
Put/Call ratio
-
64%
-
Number of buys
-
32
-
Number of sells
-
-20
-
Price
-
$8.97
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q2 2019
64 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q2 2019.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,421,031 shares
of 79,310,345 outstanding shares and own 6.8% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,397,415 shares), VANGUARD GROUP INC (1,032,482 shares), ELLIOTT MANAGEMENT CORP (833,373 shares), STATE STREET CORP (386,745 shares), Cresset Asset Management, LLC (329,796 shares), GEODE CAPITAL MANAGEMENT, LLC (293,000 shares), NUVEEN ASSET MANAGEMENT, LLC (166,541 shares), NORTHERN TRUST CORP (103,431 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (94,473 shares), and Spinnaker Capital LLC (80,384 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.